NUMG - ETF AI Analysis

Top Page

Nuveen ESG Mid-Cap Growth ETF (NUMG)

Rating:69Neutral

Price Target:―

NUMG, the Nuveen ESG Mid-Cap Growth ETF, has a solid overall rating, reflecting a portfolio led by strong performers like Comfort Systems USA, Idexx Laboratories, and Keysight Technologies, all of which show healthy revenue growth, solid cash flow, and positive earnings outlooks that support the fund’s quality. However, holdings such as Axon and Alnylam Pharmaceuticals, where high valuations, bearish or mixed technical signals, and leverage or profitability concerns appear, may be weighing on the rating, and investors should also be mindful that several top positions share the common risk of being viewed as relatively expensive.

Positive Factors

Strong Leading Holdings

Several of the largest positions, such as Ciena, Quanta Services, Comfort Systems, EMCOR Group, and Interactive Brokers, have shown strong gains, helping support the fund’s overall results.

Sector Diversification Within Growth Areas

The ETF spreads its investments across technology, industrials, health care, consumer cyclical, and other sectors, which helps reduce the impact if any one industry struggles.

Moderate Expense Ratio for an ESG Strategy

The fund’s expense ratio is moderate for an ESG-focused, actively designed mid-cap growth ETF, so fees are not excessively high relative to its specialized approach.

Negative Factors

Recent Weak Overall Performance

The ETF’s returns have been weak over the year to date and over the last three months, which may concern investors looking for steady short-term performance.

Concentration in a Handful of Stocks

The top 10 holdings make up a sizable portion of the portfolio, so poor results from just a few companies could noticeably hurt the fund.

Heavy U.S.-Only Exposure

With almost all assets invested in U.S. companies, the fund offers little geographic diversification and is highly tied to the U.S. market’s ups and downs.

NUMG vs. SPDR S&P 500 ETF (SPY)

AUM365.25M

RegionNorth America

Expense Ratio0.31%

Beta1.11

IssuerNuveen

Inception DateDec 13, 2016

Dividend Yield0.01%

Asset ClassEquity

Index TrackedMSCI Nuveen ESG USA Mid Cap Growth

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume16,193

30 Day Avg. Volume27,405

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

54.80

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering43

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

NUMG Summary

Nuveen ESG Mid-Cap Growth ETF (NUMG) tracks the MSCI Nuveen ESG USA Mid Cap Growth Index, focusing on medium‑sized U.S. companies that are growing quickly and meet environmental, social, and governance (ESG) standards. It holds innovative businesses like Datadog and Idexx Laboratories, with big weights in technology, industrials, and health care. Someone might invest in NUMG to seek long‑term growth while supporting companies that follow more sustainable and responsible practices, and to diversify beyond large, well-known stocks. A key risk is that growth and mid‑cap stocks can be more volatile, so the ETF’s price can rise and fall sharply with the market.

How much will it cost me?The Nuveen ESG Mid-Cap Growth ETF (NUMG) has an expense ratio of 0.31%, which means you’ll pay $3.10 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed, focusing on selecting mid-cap growth companies that meet strict ESG criteria.

What would affect this ETF?The Nuveen ESG Mid-Cap Growth ETF (NUMG) could benefit from increased interest in ESG investing and the growth potential of mid-cap companies, particularly in sectors like Technology and Health Care, which are known for innovation. However, it may face challenges from economic downturns, rising interest rates that could impact growth stocks, or regulatory changes affecting ESG criteria. Its focus on U.S. mid-cap stocks also makes it sensitive to domestic economic conditions and sector-specific trends.

NUMG Top 10 Holdings

NUMG’s story is all about U.S. mid-cap growth names with an ESG tilt, and it leans heavily on tech and industrials. Datadog has been the star of the show lately, with its AI-focused software engine giving the fund a strong push. Ciena and Comfort Systems are also rising steadily, adding reliable fuel from communications and industrial services. On the flip side, Carvana, Idexx Laboratories, and Alnylam Pharma are losing steam, acting as small speed bumps. Overall, the fund is concentrated in U.S.-based, tech-and-industry-driven growth stories.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
DDOG	Datadog	4.40%	$16.04M	$83.38B	90.87%	69 Neutral
LITE	Lumentum Holdings	4.10%	$14.95M	$69.21B	1017.52%	61 Neutral
FIX	Comfort Systems	4.10%	$14.95M	$64.89B	281.07%	80 Outperform
CIEN	Ciena	3.72%	$13.58M	$63.02B	518.04%	70 Outperform
IDXX	Idexx Laboratories	3.17%	$11.57M	$44.01B	7.30%	78 Outperform
EBAY	eBay	3.15%	$11.50M	$48.67B	40.40%	70 Outperform
KEYS	Keysight Technologies	2.93%	$10.68M	$58.11B	121.68%	77 Outperform
AXON	Axon Enterprise	2.83%	$10.31M	$35.96B	-43.41%	58 Neutral
ALNY	Alnylam Pharma	2.79%	$10.17M	$38.64B	-8.16%	60 Neutral
EME	EMCOR Group	2.75%	$10.05M	$36.06B	72.22%	73 Outperform

NUMG Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

44.84

Positive

100DMA

44.11

Positive

200DMA

46.15

Positive

Market Momentum

MACD

0.28

Positive

RSI

54.77

Neutral

STOCH

41.44

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For NUMG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 46.22, equal to the 50-day MA of 44.84, and equal to the 200-day MA of 46.15, indicating a bullish trend. The MACD of 0.28 indicates Positive momentum. The RSI at 54.77 is Neutral, neither overbought nor oversold. The STOCH value of 41.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NUMG.

NUMG Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
NUMG	―	―	$365.25M	0.31%	69 Neutral
FNY	―	―	$556.43M	0.73%	69 Neutral
RFG	―	―	$342.97M	0.35%	73 Outperform
GLRY	―	―	$157.29M	0.80%	75 Outperform
FRTY	―	―	$141.19M	0.60%	60 Neutral
TMFM	―	―	$113.36M	0.85%	68 Neutral

Performance Comparison

NUMG

Nuveen ESG Mid-Cap Growth ETF

46.43

-0.87

-1.84%

FNY

First Trust Mid Cap Growth AlphaDEX Fund

―

RFG

Invesco S&P Midcap 400 Pure Growth ETF

―

GLRY

Inspire Faithward Mid Cap Momentum ESG ETF

―

FRTY

Alger Mid Cap 40 ETF

―

TMFM

Motley Fool Mid-Cap Growth ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents